NEJM This Week cover image

NEJM This Week — July 17, 2025

NEJM This Week

00:00

Intro

This chapter reviews recent advancements in treating gastric and gastroesophageal junction cancer through a phase 3 trial. It highlights how the combination of Dervalumab with FLOT chemotherapy enhanced event-free survival, suggesting the integration of immunotherapy in treating these cancers.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app